| Product Code: ETC7376437 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Oncology Molecular Diagnostic Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Oncology Molecular Diagnostic Market - Industry Life Cycle |
3.4 Grenada Oncology Molecular Diagnostic Market - Porter's Five Forces |
3.5 Grenada Oncology Molecular Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Grenada Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Grenada Oncology Molecular Diagnostic Market Revenues & Volume Share, By Test Location, 2021 & 2031F |
3.8 Grenada Oncology Molecular Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Grenada Oncology Molecular Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Grenada Oncology Molecular Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Grenada |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Technological advancements in molecular diagnostics for oncology |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities in Grenada |
4.3.2 High cost associated with molecular diagnostic tests |
4.3.3 Lack of skilled healthcare professionals specializing in oncology molecular diagnostics |
5 Grenada Oncology Molecular Diagnostic Market Trends |
6 Grenada Oncology Molecular Diagnostic Market, By Types |
6.1 Grenada Oncology Molecular Diagnostic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.5 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.1.8 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.9 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Grenada Oncology Molecular Diagnostic Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2.3 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2.4 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Grenada Oncology Molecular Diagnostic Market, By Test Location |
6.3.1 Overview and Analysis |
6.3.2 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.3 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Other Establishments, 2021- 2031F |
6.3.4 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Point of Care, 2021- 2031F |
6.4 Grenada Oncology Molecular Diagnostic Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By PCR, 2021- 2031F |
6.4.3 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Multiplex, 2021- 2031F |
6.4.4 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.5 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.4.6 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021- 2031F |
6.4.7 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Chips and Microarrays, 2021- 2031F |
6.4.8 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Grenada Oncology Molecular Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Grenada Oncology Molecular Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
7 Grenada Oncology Molecular Diagnostic Market Import-Export Trade Statistics |
7.1 Grenada Oncology Molecular Diagnostic Market Export to Major Countries |
7.2 Grenada Oncology Molecular Diagnostic Market Imports from Major Countries |
8 Grenada Oncology Molecular Diagnostic Market Key Performance Indicators |
8.1 Rate of adoption of molecular diagnostic tests in oncology |
8.2 Number of research and development partnerships for oncology molecular diagnostics in Grenada |
8.3 Patient outcomes improvement rate post implementation of molecular diagnostic tests |
9 Grenada Oncology Molecular Diagnostic Market - Opportunity Assessment |
9.1 Grenada Oncology Molecular Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Grenada Oncology Molecular Diagnostic Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Grenada Oncology Molecular Diagnostic Market Opportunity Assessment, By Test Location, 2021 & 2031F |
9.4 Grenada Oncology Molecular Diagnostic Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Grenada Oncology Molecular Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Grenada Oncology Molecular Diagnostic Market - Competitive Landscape |
10.1 Grenada Oncology Molecular Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Grenada Oncology Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here